These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10453276)

  • 1. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone.
    Lange PH; Vessella RL
    Cancer Metastasis Rev; 1998-1999; 17(4):331-6. PubMed ID: 10453276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer.
    Deguchi T; Yang M; Ehara H; Ito S; Nishino Y; Takahashi Y; Ito Y; Shimokawa K; Tanaka T; Imaeda T; Doi T; Kawada Y
    Br J Cancer; 1997; 75(5):634-8. PubMed ID: 9043017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): technical and clinical aspects.
    Corey E; Corey MJ
    Int J Cancer; 1998 Aug; 77(5):655-73. PubMed ID: 9688296
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
    Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
    Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
    Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
    Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
    Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of bone marrow micrometastases in patients with prostate cancer.
    Wood DP; Banks ER; Humphreys S; McRoberts JW; Rangnekar VM
    Cancer; 1994 Nov; 74(9):2533-40. PubMed ID: 7522952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.
    Tremblay RR; Deperthes D; Têtu B; Dubé JY
    Am J Pathol; 1997 Feb; 150(2):455-9. PubMed ID: 9033261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
    Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
    Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular approach to detection of micrometastatic prostatic cancer cells in the lymph nodes and the bone marrow].
    Deguchi T; Yang M; Nishino Y; Ehara H; Takahashi Y; Kawata Y; Ito S; Ito Y; Doi T
    Hinyokika Kiyo; 1996 Oct; 42(10):787-90. PubMed ID: 8951476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of osteoblastic bone metastasis of prostate cancer].
    Yonou H; Ogawa Y; Ochiai A
    Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
    Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
    Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
    Reddi AH; Roodman D; Freeman C; Mohla S
    J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is skeletal alkaline phosphatase a valid staging marker in detection of osteoblastic skeletal metastases of prostate carcinoma?].
    Wirtz DC; Wolff JM; Ittel TH; Jakse G; Niethard FU
    Z Orthop Ihre Grenzgeb; 1998; 136(3):255-9. PubMed ID: 9736988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
    Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW
    Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Saeid MS; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1999 May; 53(5):939-44. PubMed ID: 10223487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.